reference/22330057

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22330057

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2041-4889
issueIdentifier	12
pageRange	944-
publicationName	Cell Death & Disease
startingPage	944
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dd8dad6262de5bf5cea815b6a15dd4ee http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a0d07cfe2277993e9cdb73248f10164b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1080404dfe5bff8daaf0c4b186709858 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_14b9a1269f92b1d36b53a3ed27708841
bibliographicCitation	Nguyen CH, Bauer K, Hackl H, Schlerka A, Koller E, Hladik A, Stoiber D, Zuber J, Staber PB, Hoelbl-Kovacic A, Purton LE, Grebien F, Wieser R. All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia. Cell Death & Disease. 2019 Dec 10;10(12):944. doi: 10.1038/s41419-019-2172-2.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4055-3841 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74e6c898b379c16277356c22aecb58f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bcaa6c41a5c5ddb4ccb7f48350d3ad0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4125-224X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9809591c2335e1e97631b72dd0ad005c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3f543f0487e61ef8c03038773cb753a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6094-6031 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2af1c0ada3214f9afb259a7dfa29b56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48fe87aed8a58f6f06101e87b821aad6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4289-2281 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4384-6658 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6593-3168 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8810-6835 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2ec82031635dc4c5eb8179bb403ab31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2af052538dc920506d2ba5fdd17dc4ca
date	2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31822659 https://pubmed.ncbi.nlm.nih.gov/PMC6904467 https://doi.org/10.1038/s41419-019-2172-2
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37956 https://portal.issn.org/resource/ISSN/2041-4889
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
discusses	http://id.nlm.nih.gov/mesh/M0198861 http://id.nlm.nih.gov/mesh/M0472412 http://id.nlm.nih.gov/mesh/M000626997 http://id.nlm.nih.gov/mesh/M000625171 http://id.nlm.nih.gov/mesh/M0021879 http://id.nlm.nih.gov/mesh/M0472411
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0c005fdea8148f3f10fa1f07193c381e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bbda454c2bc2a9cc4e7939b49fc7bad9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a2ba51fcc3715c279db6fe04b7505aee http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_06a26ab7727fd9df89954a41f202f77e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2122 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14013

Total number of triples: 52.